[1]
Clayton, R. et al. 2014. A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration resistant prostate cancer. Canadian Urological Association Journal. 8, 9-10 (Sep. 2014), e583–90. DOI:https://doi.org/10.5489/cuaj.1891.